Patients with NAFLD were significantly taller and presented higher mean values of ALT, fasting glucose, hemoglobin, platelet, TC, LDL, TG, and uric acid, and lower mean values of creatinine and HDL than non-NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.